Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 16, 2015
Regulation of NKT Cell Localization in Homeostasis and InfectionDrew Slauenwhite, Brent Johnston
Immunology and Cell Biology|June 23, 2015
Reconstitution models to evaluate natural killer T cell function in tumor controlSimon Gebremeskel, Drew Slauenwhite, Brent Johnston
Oncoimmunology|May 8, 2015
Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in miceSimon Gebremeskel, Daniel R Clattenburg, Drew Slauenwhite, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 19, 2014
Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen-induced arthritis by the chemokine receptor CXCR6Drew Slauenwhite, Simon Gebremeskel, Carolyn D Doucette, et al.
European Journal of Immunology|April 5, 2014
CCR4 and CXCR3 play different roles in the migration of T cells to inflammation in skin, arthritic joints, and lymph nodesNadia A Al-Banna, Maria Vaci, Drew Slauenwhite, et al.
Frontiers in Immunology|June 6, 2024
Differences in IDO1+ dendritic cells and soluble CTLA-4 are associated with differential clinical responses to methotrexate treatment in rheumatoid arthritisAnikó E Malik, Drew Slauenwhite, Sarah M McAlpine, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 24, 2022
Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twinsNora Alrumayyan, Drew Slauenwhite, Sarah M McAlpine, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 11, 2020
Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDrew Slauenwhite, Sarah M McAlpine, John G Hanly, et al.
Frontiers in Medicine|October 14, 2024
Differential type I and type III interferon expression profiles in rheumatoid and juvenile idiopathic arthritisAnikó E Malik, Drew Slauenwhite, Sarah M McAlpine, et al.
Biomarker Research|October 29, 2025
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancerOlivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, et al.
Pageof 1